Decrease in Oral Contraceptive Fills Seen After Dobbs Ruling

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, June 26, 2024 -- The Dobbs v Jackson Women's Health Organization decision, allowing states to strengthen restrictions on abortion access, was associated with declines in prescription fills for oral contraceptives, according to a study published online June 26 in JAMA Network Open.

Dima M. Qato, Pharm.D., M.P.H., Ph.D., from the University of Southern California, Los Angeles, and colleagues obtained data on contraceptive fills for women of reproductive age (15 to 49 years) in the United States. Changes in monthly fill rates were compared for daily oral contraceptive pills (OCPs) and emergency contraceptives (ECs) in states that became most restrictive (implemented a full abortion ban) and comparison states (kept a medium level of abortion restrictions) using a difference-in-differences analysis.

The researchers found that 142.8 million prescriptions for OCPs and 904,269 prescriptions for ECs were dispensed at U.S. retail pharmacies between March 2021 and October 2023. Trends in monthly fill rates were similar for OCPs and ECs between the most restrictive and comparison states before Dobbs. After Dobbs, an additional 4.1 percent decline in OCP fills was seen in states that became the most restrictive, with 285.9 fewer fills per 100,000. In contrast to OCPs, in both groups of states, fills for ECs increased during the first year after Dobbs. However, the most restrictive states experienced an additional 65 percent decrease in EC fills one year after Dobbs, with 13.2 fewer fills per 100,000.

"These findings are important given ongoing debates regarding protecting contraceptive access post-Dobbs in the United States," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-06-27 01:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords